XML 46 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Feb. 01, 2025
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents in the Consolidated Balance Sheets, that reconcile to the amounts shown on the Consolidated Statements of Cash Flows:

($000)202420232022
Cash and cash equivalents$4,730,744 $4,872,446 $4,551,876 
Restricted cash and cash equivalents included in:
Prepaid expenses and other17,087 14,489 12,677 
Other long-term assets48,631 48,506 47,688 
Total restricted cash and cash equivalents65,718 62,995 60,365 
Total cash and cash equivalents, and restricted cash and cash equivalents$4,796,462 $4,935,441 $4,612,241 
Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents in the Consolidated Balance Sheets, that reconcile to the amounts shown on the Consolidated Statements of Cash Flows:

($000)202420232022
Cash and cash equivalents$4,730,744 $4,872,446 $4,551,876 
Restricted cash and cash equivalents included in:
Prepaid expenses and other17,087 14,489 12,677 
Other long-term assets48,631 48,506 47,688 
Total restricted cash and cash equivalents65,718 62,995 60,365 
Total cash and cash equivalents, and restricted cash and cash equivalents$4,796,462 $4,935,441 $4,612,241 
Schedule of Other Long-Term Assets Other long-term assets as of February 1, 2025 and February 3, 2024 consisted of the following:
($000)20242023
Deferred compensation (Note G)$196,786 $165,582 
Restricted cash and cash equivalents48,631 48,506 
Other33,958 29,141 
Total$279,375 $243,229 
Supplier Finance Program
The following table is a reconciliation of the outstanding obligations confirmed as valid under the Company’s supply chain finance program for fiscal 2024:

($000)2024
Confirmed obligations outstanding at the beginning of the year$146,937 
Invoices confirmed during the year856,294 
Confirmed invoices paid during the year(844,022)
Confirmed obligations outstanding at the end of the year$159,209 
Summary of Insurance Obligations Self-insurance and deductible reserves as of February 1, 2025 and February 3, 2024 consisted of the following:
($000)20242023
Workers’ compensation$70,747 $80,791 
General liability58,460 47,663 
Medical plans7,938 8,145 
Total$137,145 $136,599 
Schedule of Other Long-Term Liabilities Other long-term liabilities as of February 1, 2025 and February 3, 2024 consisted of the following:
($000)20242023
Deferred compensation (Note G)$196,786 $165,582 
Income taxes (Note F)61,292 56,045 
Other9,833 10,756 
Total$267,911 $232,383 
Schedule of Disaggregation of Revenue
The following sales mix table disaggregates revenue by merchandise category for fiscal 2024, 2023, and 2022:

2024
1
20232022
Home Accents and Bed and Bath26 %26 %26 %
Ladies22 %23 %24 %
Men’s16 %15 %15 %
Accessories, Lingerie, Fine Jewelry, and Cosmetics15 %15 %14 %
Shoes12 %13 %12 %
Children’s9 %8 %9 %
Total100 %100 %100 %
Schedule of Components of Interest (Income) Expense, Net
The table below shows the components of interest (income) expense, net for fiscal 2024, 2023, and 2022:

($000)202420232022
Interest income$(234,955)$(238,207)$(77,706)
Capitalized interest expense(19,447)(12,106)(5,678)
Other interest expense1,571 1,599 1,668 
Interest expense on long-term debt81,263 84,596 84,558 
Interest (income) expense, net$(171,568)$(164,118)$2,842 
Schedule of Basic and Diluted EPS
The following is a reconciliation of the number of shares (denominator) used in the basic and diluted EPS computations:

Shares in (000s)Basic EPSEffect of dilutive
common stock
equivalents		Diluted
EPS
2024
Shares328,593 2,391 330,984 
Amount$6.36 $(0.04)$6.32 
2023
Shares335,187 2,246 337,433 
Amount$5.59 $(0.03)$5.56 
2022
Shares343,452 1,770 345,222 
Amount$4.40 $(0.02)$4.38